Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2008 1
2009 1
2010 2
2011 3
2012 3
2013 3
2014 7
2015 6
2016 5
2017 3
2018 8
2019 4
2020 9
2021 7
2022 9
2023 11
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

73 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for siping pan
Search for Suping Pan instead (1 results)
The role of tetraspanins pan-cancer.
Huang R, Sun H, Lin R, Zhang J, Yin H, Xian S, Li M, Wang S, Li Z, Qiao Y, Jiang M, Yan P, Meng T, Huang Z. Huang R, et al. iScience. 2022 Jul 19;25(8):104777. doi: 10.1016/j.isci.2022.104777. eCollection 2022 Aug 19. iScience. 2022. PMID: 35992081 Free PMC article.
Tetraspanins (TSPANs) are a class of four-transmembrane segmented proteins. The precise functions of TSPANs and their roles in pan-cancer are unclear. In this work, we analyzed TSPAN1, TSPAN10, TSPAN11, TSPAN12, TSPAN13, TSPAN14, TSPAN15, TSPAN16, TSPAN17, TSPAN18, TSPAN18 …
Tetraspanins (TSPANs) are a class of four-transmembrane segmented proteins. The precise functions of TSPANs and their roles in pan-ca …
The effect of critical illness insurance in China.
Fang P, Pan Z, Zhang X, Bai X, Gong Y, Yin X. Fang P, et al. Medicine (Baltimore). 2018 Jul;97(27):e11362. doi: 10.1097/MD.0000000000011362. Medicine (Baltimore). 2018. PMID: 29979420 Free PMC article.
The share of medical expenses reimbursed by insurance and the percentage of individuals suffering catastrophic health expenditures were calculated to evaluate the effect of critical illness insurance.The share of medical expenses reimbursed by insurance was 58.93%, 47.29%, 62.05% …
The share of medical expenses reimbursed by insurance and the percentage of individuals suffering catastrophic health expenditures were calc …
Pan-cancer analysis of the prognostic and immunological role of BRCA1-associated protein 1 gene (BAP1): Friend or foe?
Wang T, Zhu T, Zhang Y, Bai J, Xue Y, Xu G, Lu L, Peng Q. Wang T, et al. Gene. 2022 Oct 5;840:146765. doi: 10.1016/j.gene.2022.146765. Epub 2022 Jul 26. Gene. 2022. PMID: 35905855
However, it has not yet been elucidated whether BAP1 modulates the pathogenesis and progression of human cancers through some common cellular and molecular mechanisms, and a pan-cancer analysis for the roles of BAP1 has not yet been conducted. ...
However, it has not yet been elucidated whether BAP1 modulates the pathogenesis and progression of human cancers through some common cellula …
The Role of Peroxisome Proliferator-Activated Receptors (PPARs) in Pan-Cancer.
Huang R, Zhang J, Li M, Yan P, Yin H, Zhai S, Zhu X, Hu P, Zhang J, Huang L, Li M, Sun Z, Meng T, Yang D, Huang Z. Huang R, et al. PPAR Res. 2020 Sep 22;2020:6527564. doi: 10.1155/2020/6527564. eCollection 2020. PPAR Res. 2020. PMID: 33029111 Free PMC article.
We performed multidimensional analyses on PPARA, PPARG, PPARD, PPARGC1A, and PPARGC1B, including differential expression analysis in pan-cancer, immune subtype analysis, clinical analysis, tumor purity analysis, stemness correlation analysis, and drug responses. ...This an …
We performed multidimensional analyses on PPARA, PPARG, PPARD, PPARGC1A, and PPARGC1B, including differential expression analysis in pan …
A Global Building Occupant Behavior Database.
Dong B, Liu Y, Mu W, Jiang Z, Pandey P, Hong T, Olesen B, Lawrence T, O'Neil Z, Andrews C, Azar E, Bandurski K, Bardhan R, Bavaresco M, Berger C, Burry J, Carlucci S, Chvatal K, De Simone M, Erba S, Gao N, Graham LT, Grassi C, Jain R, Kumar S, Kjærgaard M, Korsavi S, Langevin J, Li Z, Lipczynska A, Mahdavi A, Malik J, Marschall M, Nagy Z, Neves L, O'Brien W, Pan S, Park JY, Pigliautile I, Piselli C, Pisello AL, Rafsanjani HN, Rupp RF, Salim F, Schiavon S, Schwee J, Sonta A, Touchie M, Wagner A, Walsh S, Wang Z, Webber DM, Yan D, Zangheri P, Zhang J, Zhou X, Zhou X. Dong B, et al. Sci Data. 2022 Jun 28;9(1):369. doi: 10.1038/s41597-022-01475-3. Sci Data. 2022. PMID: 35764639 Free PMC article.
Chiglitazar monotherapy with sitagliptin as an active comparator in patients with type 2 diabetes: a randomized, double-blind, phase 3 trial (CMAS).
Jia W, Ma J, Miao H, Wang C, Wang X, Li Q, Lu W, Yang J, Zhang L, Yang J, Wang G, Zhang X, Zhang M, Sun L, Yu X, Du J, Shi B, Xiao C, Zhu D, Liu H, Zhong L, Xu C, Xu Q, Liang G, Zhang Y, Li G, Gu M, Liu J, Yuan G, Yan Z, Yan D, Ye S, Zhang F, Ning Z, Cao H, Pan D, Yao H, Lu X, Ji L. Jia W, et al. Sci Bull (Beijing). 2021 Aug 15;66(15):1581-1590. doi: 10.1016/j.scib.2021.02.027. Epub 2021 Feb 16. Sci Bull (Beijing). 2021. PMID: 36654287 Free article. Clinical Trial.
Chiglitazar (Carfloglitazar) is a novel peroxisome proliferator-activated receptor (PPAR) pan-agonist that has shown promising effects on glycemic control and lipid regulation in patients with type 2 diabetes. ...The overall results demonstrated that chiglitazar possesses …
Chiglitazar (Carfloglitazar) is a novel peroxisome proliferator-activated receptor (PPAR) pan-agonist that has shown promising effect …
Fotagliptin monotherapy with alogliptin as an active comparator in patients with uncontrolled type 2 diabetes mellitus: a randomized, multicenter, double-blind, placebo-controlled, phase 3 trial.
Xu M, Sun K, Xu W, Wang C, Yan D, Li S, Cong L, Pi Y, Song W, Sun Q, Xiao R, Peng W, Wang J, Peng H, Zhang Y, Duan P, Zhang M, Liu J, Huang Q, Li X, Bao Y, Zeng T, Wang K, Qin L, Wu C, Deng C, Huang C, Yan S, Zhang W, Li M, Sun L, Wang Y, Li H, Wang G, Pang S, Zheng X, Wang H, Wang F, Su X, Ma Y, Zhang W, Li Z, Xie Z, Xu N, Ni L, Zhang L, Deng X, Pan T, Dong Q, Wu X, Shen X, Zhang X, Zou Q, Jiang C, Xi J, Ma J, Sun J, Yan L. Xu M, et al. BMC Med. 2023 Oct 9;21(1):388. doi: 10.1186/s12916-023-03089-x. BMC Med. 2023. PMID: 37814306 Free PMC article. Clinical Trial.
The regulation role and diagnostic value of fibrinogen-like protein 1 revealed by pan-cancer analysis.
Yi W, Qiao T, Yang Z, Hu L, Sun M, Fan H, Xu Y, Lv Z. Yi W, et al. Mater Today Bio. 2022 Oct 20;17:100470. doi: 10.1016/j.mtbio.2022.100470. eCollection 2022 Dec 15. Mater Today Bio. 2022. PMID: 36345363 Free PMC article.
Although the role of fibrinogen-like protein 1 (FGL1) in tumorigenesis is well known, a pan-cancer analysis of FGL1 lacks. We used bioinformatics techniques to analyze cancer data from publicly available datasets from The Cancer Genome Atlas, UALCAN, TIMER, Gene Expression …
Although the role of fibrinogen-like protein 1 (FGL1) in tumorigenesis is well known, a pan-cancer analysis of FGL1 lacks. We used bi …
73 results